Tell us why INO's platform avoids the severe and sometimes fatal immunological side-effects caused by t-cell activation and proliferation caused by a DNA therapy such as BMY's Yervoy.
INO patented synthetic process of producing actives with minimal adverse effects (from INOpedia)
This is actually how it appears on wikipedia.
Ipilimumab treatment has been associated with severe and potentially fatal immunological adverse effects due to T cell activation and proliferation.
Love how you replace the word potentially with the word sometimes. Think there might be a difference? A jury might think so Harry. LOL